Gene: ANKRD37
Official Full Name: ankyrin repeat domain 37provided by HGNC
Gene Summary: Located in cytosol; mitochondrion; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19828 | ANKRD37 Knockout cell line (HeLa) | Human | ANKRD37 | 1:3~1:6 | Negative | Online Inquiry |
KO19829 | ANKRD37 Knockout cell line (HCT 116) | Human | ANKRD37 | 1:2~1:4 | Negative | Online Inquiry |
KO19830 | ANKRD37 Knockout cell line (HEK293) | Human | ANKRD37 | 1:3~1:6 | Negative | Online Inquiry |
KO19831 | ANKRD37 Knockout cell line (A549) | Human | ANKRD37 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD37 Gene Knockout Cell Lines represent a cutting-edge tool for biomedical research, specifically designed to facilitate the study of gene function and its implications in various biological processes. These custom-designed cell lines have been genetically modified to completely eliminate expression of the ANKRD37 gene, enabling researchers to investigate its role in cell signaling, metabolic pathways, and potential disease mechanisms, particularly in cancer progression and developmental biology.
The functionality of these knockout cell lines is rooted in CRISPR-Cas9 technology, which provides precision in gene editing by inducing targeted double-strand breaks in the DNA, leading to permanent gene disruption. By employing this advanced method, the resulting cell lines allow for the unobstructed observation of cellular behaviors and phenotypic changes that arise from the absence of ANKRD37, illuminating its functional significance in health and disease.
The scientific importance of ANKRD37 Gene Knockout Cell Lines is underscored by their potential applications in both basic and applied research. Researchers can utilize these lines to explore therapeutic targets for drug discovery, improve understanding of gene interactions, and develop models for diseases attributed to dysregulation of the ANKRD37 gene. Furthermore, they serve as critical components in high-throughput screening assays and systems biology studies.
Compared to conventional methods that often rely on transient transfection or RNA interference, our ANKRD37 knockout lines provide a stable, long-term solution for gene disruption. This stability minimizes variability, ensures reproducibility of results, and bolsters the reliability of experimental findings. Additionally, these cells are compatible with various cell types, enabling flexible applications across multiple research domains.
For researchers and clinicians, the value of the ANKRD37 Gene Knockout Cell Lines lies in their potential to accelerate discovery and innovatively pursue breakthroughs in understanding gene function. With our extensive expertise in gene editing technologies and a commitment to providing high-quality biological products, we empower scientific inquiry and foster advancements in medical research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.